drugset / Trial / NCT05080946
Using Aspirin to Improve Immunological Features of Ovarian Tumors
Phase 0
Suspended
100 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Sharp · collabUnited States Department of Defense · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
Timeline
- Start
- 2021-11-02
- Primary completion
- 2026-11
- Completion
- 2026-12
Outcome
Outcome not reported
Stopped: “Study drug is expiring. Will reopen when new drug is received.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 325 mg | Oral |